http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105671064-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105671064-B |
titleOfInvention | Recombinant antigen gene, recombinant antigen protein and the subunit vaccine composition of anti-porcine reproductive and respiratory syndrome virus infection |
abstract | The present invention relates to a kind of recombination fusion antigen genes of anti-porcine reproductive and respiratory syndrome viral (PRRSV) infection, recombinate fusion antigen protein and the subunit vaccine composition containing it, it is that PRRSV is had the glycoprotein GP5 for truncating the end N ' decoy epitopes, after catenation sequence and memebrane protein M are fused to recombination sequence and carry out codon optimization, resulting recombination fusion antigen gene carries out vivoexpression using recombinant baculovirus expression system, its yield for recombinating fusion antigen protein can not only be promoted, resulting recombination fusion antigen protein is when being applied to subunit vaccine composition, preferable vaccine protection can be provided to immunized animal not have toxin expelling again and return malicious risk. |
priorityDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.